8-K: Adia Nutrition Files Lawsuit Over Stock Ownership

Adia Nutrition has initiated a legal action seeking to quiet title on over 29 million shares of its common stock, alleging they were improperly issued.

Summary

• Adia Med, Inc. has filed a Verified Complaint for Declaratory Judgment in Florida to resolve ownership of 29,059,792 shares of its non-preferred common stock.
• These shares represent 30.78% of the company's issued and outstanding shares and had a market value of approximately $3.49 million as of August 13, 2026.
• The lawsuit names Tydus Richards as the primary defendant, with other individuals and entities identified as 'Claimants' who may have an interest in these shares.
• The company alleges that a change of control in January 2024, involving the acquisition of Series A Preferred stock, revealed no basis in company records or its transfer agent for the issuance of these shares to the Claimants.
• Adia claims the shares were not validly issued and that the Claimants never paid for them, with their purported interest resting solely on the stock transfer ledger.
• The company seeks a judgment declaring that title to these shares is quieted in Adia and an order restraining the Claimants from pursuing actions against the company for recovery of these shares.
• The outcome of the litigation is uncertain, and an adverse result would leave the shares outstanding in the names of the Claimants.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as negative due to the initiation of a significant legal dispute concerning the validity of a substantial portion of the company's shares, creating considerable uncertainty.

Negatives

• The company is initiating a significant legal battle to reclaim a substantial portion of its own stock, indicating a potential issue with its capitalization and historical issuance practices.
• The lawsuit creates substantial uncertainty regarding the true number of outstanding shares and the company's financial structure.
• The company faces potential double litigation and multiple claims for the same stock if the lawsuit is not resolved in its favor.
• Legal expenses associated with this action are unpredictable and could be significant.

Risks

• The outcome of the litigation is uncertain, and an adverse result could leave 29,059,792 shares outstanding in the names of the Claimants.
• Claimants may contest jurisdiction or venue, assert valid issuance or transfer of the shares, or bring related claims.
• The company cannot predict the timing or outcome of the action, nor the legal expenses it will incur.
• The transfer agent's role in recording any judgment and potential state corporate law requirements add complexity to the resolution.

Future Outlook

The company intends to pursue the legal action, but the outcome is uncertain. An adverse result would leave the disputed shares outstanding. The company cannot predict the timing or outcome of the action, or the amount of legal expense it will incur.

Management Comments

• The Company intends to pursue the Action.
• The outcome is uncertain.
• The Company undertakes no obligation to update these statements except as required by law.

Industry Context

StockSavvy.ai notes that disputes over share issuance and ownership, particularly in smaller publicly traded companies, can significantly impact investor confidence and market valuation. This action by Adia Nutrition highlights the importance of robust internal controls and accurate record-keeping for transfer agents.

Legal Proceedings

• Adia Med, Inc. v. Tydus Richards, Case No. 2026CA002155 (Circuit Court of the Eighteenth Judicial Circuit, Seminole County, Florida) Verified Complaint for Declaratory Judgement seeking to quiet title in 29,059,792 shares of common stock.

Stakeholder Impact

• Shareholders: The uncertainty regarding the number of outstanding shares and the potential dilution or reclassification of ownership could negatively impact share value and investor confidence.
• Creditors: A clouded share structure could potentially affect the company's financial stability and its ability to meet obligations.
• Management: Faces the challenge of resolving a complex legal dispute and managing its impact on operations and strategy.

Next Steps

• Adia Med, Inc. will pursue the legal action filed.
• The company will await a responsive pleading from the defendant and potential court proceedings.
• The transfer agent will be involved in recording any court-ordered changes to the share register.

Key Dates

Recommendation

The initiation of a lawsuit to resolve ownership of a significant portion of the company's stock introduces substantial uncertainty and risk. While the company is taking action to clarify its capital structure, the outcome is unpredictable and could materially affect the company's valuation. Therefore, a 'hold' recommendation is prudent pending the resolution of this legal matter.

Keywords

Declaratory Judgment, Stock Ownership, Shareholder Dispute, Quiet Title, Corporate Governance, Litigation, Common Stock, Transfer Agent